Supha Pharmachem Limited (SUPHA) Share Price

BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE549S01036

₹0.29-0.01 (-3.33%)

Key metrics

Market Cap
₹26 Cr
P/E Ratio
2.31
EPS
0.13
Book Value
0.76
P/B Ratio
0.38
ROE
4.85%
ROCE
1.38%
Debt / Equity
1.02
Net Margin
0.53%
Revenue Growth
-89.97%
Profit Growth
-93.49%
Dividend Yield
52W High
₹1.80
52W Low
₹0.25
Market Cap Band
micro cap
Face Value

Ratios computed from the annual results period ending 2025-03-31.

About Supha Pharmachem Limited

Supha Pharmachem Limited, a pharmaceutical company, trades and sells active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, iodine, selenium metal powder, and trimethyl sulfoxonium iodide. It also provides tartaric acid salt, thiophenetosylate, couple amine hydrochloride, pantoprazole sulphide, chloro compound, benzimidazole, pantoprazole n-oxide, 4-chloro benzhydryl piperazine, cetirizine base, levo CBP, 2 PMS, indole II, indole III, and R- amide. The company was formerly known as Remedium Lifecare Limited and changed its name to Supha Pharmachem Limited in December 2025. Supha Pharmachem Limited was incorporated in 1988 and is based in Mumbai, India.

Headquarters
Mumbai, India
Employees
7
Promoter Holding
20.14%

The full Supha Pharmachem Limited analysis

Create a free account to open the complete SUPHA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.

  • 10-year financialsIncome statement, balance sheet and cash flow, year by year.
  • Valuation & fair valueFair-value estimates, quality scores and a value grade.
  • Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
  • Shareholding historyPromoter, FII, DII and public holdings across every quarter.
  • Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
  • Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.